Global Reach Bentley has an international distribution network covering more than 80 countries, with some markets where it is a market leader. This presents sales opportunities for expanding adoption of its covered balloon expandable stents and new Be graft products through existing partners and potential new distributors in high-potential vascular markets.

Unique Offering The company uniquely offers a covered balloon expandable stent range from 2.5 mm to 30 mm, targeting cardiologists, endovascular surgeons, and interventional radiologists. This differentiation supports cross-selling across multiple vascular indications and invites collaboration with hospitals seeking comprehensive endovascular solutions.

Product Momentum A pipeline of high-profile products through 2025 including BeGraft and BeFlow/BeFlared lines indicates ongoing portfolio expansion. Sales strategies can align with product launches and clinical education initiatives to drive adoption in new indications such as aortic and iliac applications.

Growth Partners Reliance on an international network of exclusive distribution partners suggests opportunities to optimize partner performance, expand into additional markets, and co-market with distributors to accelerate uptake in underserved regions, particularly where leadership positions exist.

Tech & Data Existing tech stack including Snowflake and Microsoft platforms implies potential for data-driven sales enablement, territory analytics, and performance tracking. Leverage analytics to identify high-potential hospitals, tailor value propositions, and measure ROI from implant adoption campaigns.